Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,900.00
+50.00 (0.85%)
Last updated: May 14, 2026, 3:00 PM KST
Market Cap577.19B +120.7%
Revenue (ttm)200.71B +25.4%
Net Income12.56B
EPS152.00
Shares Out98.66M
PE Ratio38.49
Forward PEn/a
Dividend150.00 (2.56%)
Ex-Dividend DateDec 29, 2025
Volume1,306,070
Average Volume1,863,211
Open5,890.00
Previous Close5,850.00
Day's Range5,810.00 - 6,080.00
52-Week Range3,200.00 - 9,890.00
Beta0.23
RSI36.79
Earnings DateApr 21, 2026

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication... [Read more]

Sector Healthcare
Founded 1960
Employees 615
Stock Exchange Korea Stock Exchange
Ticker Symbol 003000
Full Company Profile

Financial Performance

Financial Statements